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Background: Technique failure is an important issue for peritoneal dialysis (PD)
patients. In this study, we aimed to analyze technique failure rate in detail and to
determine the predictors for technique failure in Korea.
Methods: We identiﬁed all patients who had started dialysis between January 1,
2005, and December 31, 2008, in Korea, using the Korean Health Insurance Review
and Assessment Service database. A total of 7,614 PD patients were included, and
the median follow-up was 24.9 months.
Results: The crude incidence rates of technique failure in PD patients were 54.1 per
1,000 patient-years. The cumulative 1-, 2-, and 3-year technique failure rates of PD
patients were 4.9%, 10.3%, and 15.6%, respectively. However, those technique failure
rates by KaplaneMeier analysis were overestimated compared with the values by
competing risks analysis, and the differences increased with the follow-up period. In
multivariate analyses, diabetes mellitus and Medical Aid as a crude reﬂection of low
socioeconomic status were independent risk factors in both the Cox proportional
hazard model and Fine and Gray subdistribution model. In addition, cancer was
independently associated with a lower risk of technique failure in the Fine and Gray
model.
Conclusion: Technique failure was a major concern in patients initiating PD in
Korea, especially in diabetic patients and Medical Aid beneﬁciaries. The results of
our study offer a basis for risk stratiﬁcation for technique failure.
Copyright © 2016. The Korean Society of Nephrology. Published by Elsevier. This is
an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
There has been a signiﬁcant increase in the number of
incident dialysis patients over the past decade in Korea.rnal Medicine, School of
ok-dong, Yangcheon-gu,
ty of Nephrology. Published b
/4.0/).According to the 2012 annual report from the Korean nation-
wide registry program, the number of new end-stage renal
disease (ESRD) patients with hemodialysis (HD), peritoneal
dialysis (PD), or kidney transplantation (KT) was 8,811 (169.8
per million population [PMP]), 923 (17.8 PMP), or 1,738 (33.5
PMP), respectively [1].
Notably, the number of new patients on PD has been
decreasing since 2007, whereas the number of those on HD andy Elsevier. This is an open access article under the CC BY-NC-ND license
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observed in the United States [2]. Possible reasons for the
decreasing rate of choosing PD as an initial dialysis therapy
could include increased number of HD centers, better outcome
in HD patients [3], and concerns about PD-related complica-
tions including peritonitis. Moreover, high technique failure
rate in PD patients has contributed to the decreasing number of
prevalent PD [1].
ESRD patients on dialysis suffer not only from higher mor-
tality compared with the general population [4] but also from
high morbidity due to various cardiovascular diseases, cancer,
and technique failure. Technique failure can induce medical
stress including subsequent mortality and additional cost,
especially in the earlier period after initiation of PD [5e7].
Accordingly, there has been a continuous effort to analyze the
causes and predictors of technique failure. Nevertheless, there
are still controversial issues for technique failure risk factors
because of different medical and social environments across
countries. Although a population-based study for technique
failure was reported in Western countries, there has not been a
similar study in Asian countries. Because there are signiﬁcant
differences between Western and Asian ESRD patients in eti-
ology of renal failure and mortality rates [8], it is likely that
there are different characteristics for technique failure in Asian
patients.
In addition, it is known that there are various competing
risks in the research for outcomes in PD, and the risk of the
outcome of interest may be overestimated without consider-
ation of these competing risks [9,10].
In this study, we aimed to analyze technique failure rate in
PD in detail and to determine the speciﬁc predictors for tech-
nical failure by both conventional analysis and competing risks
analysis, using the Korean Health Insurance Review and
Assessment Service (HIRA) database, which is a nationwide,
population-based data set.
Methods
Data source and study population
We performed a retrospective cohort study that used in-
formation from the Korean HIRA database. In Korea, all medical
care expenses for dialysis are reimbursed by HIRA. Therefore,
wewere able to collect all information from every ESRD patient
and analyze data which represented the entire Korean popu-
lation. We initially identiﬁed all the incident dialysis patients
who had started PD therapy from January 1, 2005, to December
31, 2008, using detailed methods described elsewhere [3].
Among them, the patients who were younger than 18 years or
the patients who survived for less than 90 days from the date of
dialysis initiation were excluded. All included patients were
followed up until December 31, 2009. The time to death was
conﬁrmed by the Certiﬁcate Database, which records the rea-
sons for changes in eligibility for the health security system
including death or emigration, as well as by the National Health
Insurance Claims Database. Comorbidities of the participants
were identiﬁed by reviewing their medical history during the
last 1 year before the initiation of dialysis therapy. The list of
analyzed comorbidities was determined on the basis of sug-
gestions by Charlson et al [11], and International Classiﬁcation
of Diseases, 10th Revision, codes were used according to the
proposed algorithms by Quan et al [12].Deﬁnition
Technique failure was deﬁned as transference from a
speciﬁc modality of dialysis therapy to another modality that
lasted for 30 days or more, and the end point of this study
was time to technique failure. We considered the dialysis
modality at day 90 as the initial dialysis modality and
incorporated all events of shifting modality afterward. Most
of the acutely ill patients who need urgent initiation of
dialysis start dialysis preferentially with HD. Because we
could not investigate the cause of dialysis initiation, educa-
tion on dialysis modalities a priori, and referral timing, we
evaluated the technique failure rate in “long-term dialysis”
patients maintained on dialysis for 3 months or more. In
addition, although some patients switched dialysis modalities
multiple times, we only included the ﬁrst event of technique
failure for the entire analysis.
Statistical analysis
All data are expressed as mean ± standard deviation or
number (percent) unless otherwise speciﬁed. A P value < 0.05
was considered statistically signiﬁcant.
To assess technique failureefree survival, we used
KaplaneMeier survival curves with the log-rank test to
compare the differences. Patients were censored at KT, death,
or on December 31, 2009. Cox proportional hazards analysis
was performed to determine predictive factors, and signiﬁcant
variables in univariate analyses were included in multivariate
analysis with a threshold of 0.10 for retention. In addition, to
compare the technique failureefree survival rates according to
the dialysis initiation year, we constructed data sets in which
the patients were followed up to 2 years to let each year cohort
have the same follow-up period.
Next, we performed competing risks analysis because the
KaplaneMeier method is known to overestimate the proba-
bilities of each event when there are competing events in PD
patients [10,13]. In our analysis, death and KT are considered to
be competing events for technique failure. To explore the
relationship between covariates and the cumulative incidences
of each event, the Fine and Gray regression model was used. In
addition, we compared results by competing risks analysis with
those obtained by KaplaneMeier analysis.
The statistical analyses were performed using the statistic
software SPSS, version 18.0 (SPSS Inc., Chicago, IL, USA), and R
3.1.2 (R Foundation for Statistical Computing, Vienna, Austria)
including cmprsk package.
This investigationwas conducted according to the principles
expressed in the Declaration of Helsinki. The Institutional Re-
view Board at the HIRA approved the survey of the study
population.
Results
Baseline characteristics of the participants
A total of 7,614 eligible patients who started PD between
January 1, 2005, and December 31, 2008, were analyzed. At the
initiation of dialysis treatment, the mean patient age was
54.5 ± 13.8 years; 56.3% of the patients were male, and 50.4% of
the patients had diabetes. A detailed description of character-
istics among PD patients is shown in Table 1.
Table 1. Baseline characteristics (N ¼ 7,614)
Variables
Age (y) 54.5 ± 13.8
Males 4,290 (56.3)
Health security system
National Health Insurance 6,650 (87.3)
Medical Aid 964 (12.7)
Diabetes mellitus 3,836 (50.4)
Myocardial infarction 354 (4.6)
Congestive heart failure 1,224 (16.1)
Peripheral vascular disease 416 (5.5)
Cerebrovascular disease 806 (10.6)
Dementia 69 (0.9)
Chronic pulmonary disease 1,177 (15.5)
Connective tissue disease 208 (2.7)
Peptic ulcer disease 1,035 (13.6)
Hemiparesis 92 (1.2)
Liver disease 753 (9.9)
Cancer 313 (4.1)
Age is presented as the mean ± SD, and all other data are presented as
the n (%).
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During the median follow-up of 24.9 months (range,
3.0e60.0 months), 942 (12.4%) PD patients had experienced
technique failure, and the crude incidence rates of technique
failure among PD patients were 54.1 per 1,000 patient-years.
More detailed descriptions for crude incidence rates of PD
technique failure are shown in Table 2.
Median time of technique failure after initiation of dialysis
therapy among PD patients was 25.0 months (interquartile
range, 15.3e39.0 months).Cumulative incidences by KaplaneMeier analysis and
competing risks analysis
Table 3 shows the cumulative incidences calculated by
KaplaneMeier analysis and by competing risks analysis. WeTable 2. Crude incidence rates of technique failure
Subgroup Cases (N)/
patient-years
Incidence rate
(1,000/patient-years)
Sex Male 539/9,683.7 55.7
Female 403/7,743.6 52.0
Diabetes mellitus Yes 543/8,318.6 65.3
No 399/9,108.8 43.8
Age (y) < 64 718/13,545.0 53.0
65þ 224/3,882.3 57.7
Health security
system
NHI 793/15,275.1 51.9
MA 149/2,152.2 69.2
All patients Overall 942/17,427.0 54.1
MA, Medical Aid; NHI, National Health Insurance.
Table 3. Cumulative incidences of events of interest calculated by
KaplaneMeier analysis and by competing risks analysis
Years after initiation of dialysis 1 2 3 4
KaplaneMeier analysis*
Technique failure 0.049 0.103 0.156 0.195
Competing risks analysis
Technique failure 0.046 0.091 0.128 0.152
Transplantation 0.015 0.032 0.046 0.054
Death 0.100 0.190 0.258 0.316
* In KaplaneMeier analysis, transplantation and death were censored.censored death and technique failure in KaplaneMeier anal-
ysis, while all those were counted as events of interest in
competing risks analysis. In KaplaneMeier analysis, the 1-, 2-,
and 3-year cumulative incidences of technique failure among
PD patients were 4.9%, 10.3%, and 15.6%, respectively. However,
cumulative incidences of technique failure calculated by
competing risks analysis were lower than those determined by
KaplaneMeier analysis among PD patients (Table 3). Of note,
the complement of KaplaneMeier estimate (1 e KM) was
higher than the estimate of cumulative incidence by competing
risks analysis (Fig. 1).
In addition, competing risks analysis allowed calculation of
the cumulative incidence of the other outcomes, including
death and transplantation. Cumulative incidences of death
were higher than those of technique failure or transplantation.
When calculating the 1-, 2-, and 3-year survival rates from
cumulative incidences of death, the survival rates of PD patients
were 90%, 81%, and 74%, respectively.
When we compare the technique failureefree survival rates
according to the year of dialysis initiation, it was not signiﬁ-
cantly different up to 2 years among PD patients by the log-rank
test (Fig. 2; P ¼ 0.449).Comparison of cumulative incidences according to baseline
characteristics among incident PD patients
We compared cumulative incidences calculated by
competing risks analysis according to sex, age group, dia-
betes, or health security system among PD patients (Fig. 3).
There was no signiﬁcant difference in the cumulative in-
cidences of technique failure between male and female pa-
tients (P ¼ 0.362). However, cumulative incidence of
technique failure was signiﬁcantly higher in younger patients
than in elderly patients (< 65 vs.  65 years, P ¼ 0.041) and in
diabetic patients than in nondiabetics (P < 0.001). In addi-
tion, Medical Aid beneﬁciaries had higher cumulative inci-
dence of technique failure than patients covered by National
Health Insurance (P ¼ 0.002).Figure 1. Comparison of cumulative incidences of technique failure
between curves calculated by KaplaneMeier analysis and by competing
risks analysis.
Figure 2. Technique failureefree survival curves according to the year
of dialysis initiation. There was no signiﬁcant difference in technique
failureefree survival rates up to 2 years according to the year of dialysis
initiation (log-rank test, P ¼ 0.449).
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proportional hazard model versus Fine and Gray
subdistribution hazard model
Table 4 shows a summary of the unadjusted and adjusted
effects of covariates for technique failure based on the 2 typesFigure 3. Comparison of cumulative incidences of technique failure, transpl
system among PD patients.
DM, diabetes mellitus; MA, Medical Aid; NHI, National Health Insurance; PD, p
(A) There was no signiﬁcant difference in the cumulative incidences of techniqu
incidence of technique failure was signiﬁcantly higher in younger patients than
patients than in non-diabetics (P < 0.001). In addition, MA beneﬁciaries had hig
by NHI (P ¼ 0.002).of analyses: Cox proportional hazard model and Fine and Gray
subdistribution hazard model.
In the unadjusted models for technique failure, we found
that age, Medical Aid (vs. National Health Insurance), diabetes
mellitus, peripheral vascular disease, and chronic pulmonary
disease were signiﬁcant factors in the Cox proportional hazard
model, whereas Medical Aid, diabetes mellitus, and cancer
were signiﬁcant in the Fine and Gray subdistribution hazard
model. After adjusting for factors with a P < 0.10 in the uni-
variate analyses, Medical Aid (hazard ratio [HR], 1.28; 95%
conﬁdence interval [CI], 1.07e1.52; P ¼ 0.007) and diabetes
mellitus (HR, 1.42; 95% CI, 1.24e1.62; P < 0.001) remained
statistically signiﬁcant in Cox analysis. In comparison, Medical
Aid (subdistribution HR, 1.27; 95% CI, 1.07e1.52; P ¼ 0.008),
diabetes mellitus (subdistribution HR, 1.35; 95% CI, 1.19e1.54;
P < 0.001), and cancer (subdistribution HR, 0.62; 95% CI,
0.41e0.93, P ¼ 0.022) were the independent predictors for
technique failure in Fine and Gray analysis.
Discussion
In this study, we performed a national population-based
study to evaluate technique failure in Korean patients initi-
ating dialysis, using conventional survival analyses and
competing risks analysis. The crude incidence rate of technique
failure among PD patients was 54.1 per 1,000 patient-years.
Because the incidence rate represented as cases per 1,000antation, and death according to sex, age groups, DM, or health security
eritoneal dialysis.
e failure between male and female patients (P ¼ 0.362). (B-D) Cumulative
in elderly patients (< 65 years vs.  65 years, P ¼ 0.041), and in diabetic
her cumulative incidence of technique failure compared to patients covered
Table 4. Comparison between results by the Cox model and those by the Fine and Gray model for technique failure
Variables Cox proportional hazard model
(cause-speciﬁc hazard model)
Fine and Gray model (hazard of the
subdistribution model)
Univariate Multivariate* Univariate Multivariate*
HR 95% CI P HR 95% CI P sHR 95% CI P sHR 95% CI P
Age (per 1-y increase) 1.01 1.00e1.01 0.004 1.00 1.00e1.01 0.137 1.00 1.00e1.00 0.780 e e e
Female (vs. male) 0.94 0.82e1.06 0.304 e e e 0.95 0.83e1.08 0.400 e e e
MA (vs. NHI) 1.34 1.12e1.59 0.001 1.28 1.07e1.52 0.007 1.31 1.10e1.57 0.002 1.27 1.07e1.52 0.008
Diabetes mellitus 1.50 1.32e1.71 < 0.001 1.42 1.24e1.62 < 0.001 1.38 1.22e1.57 < 0.001 1.35 1.19e1.54 < 0.001
Myocardial infarction 0.96 0.69e1.35 0.827 e e e 0.78 0.55e1.09 0.140 e e e
Congestive heart failure 1.14 0.96e1.35 0.138 e e e 1.01 0.85e1.20 0.920 e e e
Peripheral vascular disease 1.32 1.01e1.72 0.043 1.17 0.90e1.54 0.241 1.18 0.91e1.55 0.210 e e e
Cerebrovascular disease 1.21 0.98e1.49 0.072 1.07 0.86e1.33 0.537 0.99 0.80e1.22 0.900 e e e
Dementia 0.96 0.43e2.14 0.916 e e e 0.69 0.31e1.56 0.370 e e e
Chronic pulmonary disease 1.23 1.04e1.46 0.017 1.17 0.99e1.40 0.061 1.14 0.96e1.35 0.140 e e e
Connective tissue disease 1.35 0.94e1.93 0.104 e e e 1.25 0.87e1.79 0.220 e e e
Peptic ulcer disease 1.01 0.84e1.22 0.926 e e e 0.96 0.80e1.16 0.680 e e e
Hemiparesis 1.57 0.94e2.61 0.085 1.43 0.85e2.43 0.182 1.30 0.78e2.16 0.310 e e e
Liver disease 0.87 0.70e1.10 0.241 e e e 0.87 0.69e1.09 0.210 e e e
Cancer 0.69 0.45e1.04 0.074 0.72 0.47e1.08 0.113 0.58 0.38e0.88 0.010 0.62 0.41e0.93 0.022
* Hazard ratios of technique failure were adjusted for all parameters with a P < 0.10 in the univariate analysis.
CI, conﬁdence interval; HR, hazard ratio; MA, Medical Aid; NHI, National Health Insurance; sHR, subdistribution hazard ratio.
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10-year incidence of events, thus it is recently regarded as
essential for risk stratiﬁcation and guiding therapy [14].
The annual technique failure rate among PD patients varies
according to the region and the period when the study was
conducted. The 2-year technique failure rate was 36% in an
earlier Dutch study and in the recent US study [15,16], which is
higher than our rate of 10.3%. However, our 3-year technique
failure rate is 15.6% and is similar to other studies that reported a
rate of 16% in the early 1980s and a rate of 16.3% in a Korean
single-center study [17,18]. Those studies were mainly con-
ducted in centers with particular experiences for treating PD
patients, and a center's experience is associated with technique
failure and mortality in PD [19]. Therefore, our results that
included all Korean PD centers, regardless of centers' experi-
ences, may not be inferior. In fact, a population-based Canadian
study, which has a similar design to our study, reported a higher
incidence of technique failure [20]. However, despite the
decreasing rate of peritonitis in Korea [21], there has been no
change in technique failure incidence over several decades. In
addition, when we compared the crude technique failureefree
survival rates among PD patients according to the dialysis
initiationyear between2005 and2008, therewere no signiﬁcant
changes across the years. Although the periodwas not enough to
investigate sequential changes, the survival rate among Korean
PD patients initiating dialysis signiﬁcantly improved from 2005
to 2008, as previously reported [22]. Therefore, technique failure
in PD persists as a major problem in Korea.
In survival analysis of dialysis patients, there are several
competing risks, such as death, transplantation, and technique
failure [10]. The KaplaneMeier method is likely to overestimate
the incidence of technique failure. In this study, the 3-year
cumulative incidence of technique failure in PD was 2.8%
higher in KaplaneMeier analysis compared to competing risks
analysis. When comparing cumulative incidence function in
competing risks analysis, we found that younger patients aged
below 65 years, diabetics, and Medical Aid beneﬁciaries
showed higher incidences of technique failure in PD patients.
Next, we also identiﬁed prognostic predictors for future
technique failure events in PD, using both the Cox proportional
hazard model and Fine and Gray subdistribution model. Ofinterest, independent predictors were not the same between
the 2 modeling methods. In Cox analysis, Medical Aid and
diabetes mellitus were signiﬁcant factors, whereas Medical Aid,
diabetes mellitus, and cancer were signiﬁcant in the Fine and
Gray model. Similarly to the previous report [23], the results in
this study were also different between the Cox model and Fine
and Gray model, thus we suggest that a competing risks anal-
ysis should be considered for the research on technique failure
among PD patients. In another previous report, female gender,
lower serum albumin, and higher body mass index were found
to be independent risk factors [24]. However, because our
database did not include laboratory data, we could not eluci-
date more valuable prognostic factors.
There were conﬂicting results in regards to age. In this study,
age was not a signiﬁcant predictor for technique failure,
whereas several studies have suggested that old age was
associated with an increased risk of technique failure in PD
[15,20]. In a comparison of cumulative incidence by 2 age
groups, however, the technique failure rate was signiﬁcantly
higher in younger patients than in elderly patients. Fear to
change and low life expectancy in elderly patients are the
possible reasons for a lower technique conversion rate. In
addition, more active decision-making in younger patients and
the easy accessibility of HD in Korea could contribute to a
higher modality conversion rate. However, we need further
investigation to evaluate the exact reason.
We also found that diabetes mellitus was an independent
factor for predicting technique failure, which is consistent
with several previous studies [25e27]. Recently, however,
Cotovio et al [28] reported that diabetes was a signiﬁcant
predictor for death in PD patients but was not a predictor for
technique failure. Moreover, another retrospective cohort
study indicated that baseline HbA1c levels greater than 6.5%
did not show a statistically signiﬁcant correlation with tech-
nique failure in PD [29].
In addition, Medical Aid beneﬁciaries had higher technique
failure rates than National Health Insurance patients. Although
low socioeconomic status did not predict fundamental out-
comes such as patient survival or technique survival for PD
patients in previous studies [16,30], it might not be a major
determinant to outcomes because the included subjects were
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from centers with a wide range of PD experiences. On the
contrary, we evaluated a technique failure rate in claims data-
base which comprised all Korean PD patients irrespective of
hospital characteristics or center experiences. In addition, poor
socioeconomic status generally put ESRD patients in a more
disadvantageous position in terms of higher mortality and
more frequent laboratory abnormalities [31,32]. Moreover,
limited health literacy, which was signiﬁcantly related to so-
cioeconomic status, is associated with health outcomes
including mortality in patients with chronic kidney disease
[33], whereas its association with adverse outcomes was not
found in a studywith 36 PD patients [34]. AlthoughMedical Aid
and National Health Insurance are a crude dichotomous clas-
siﬁcation, complex and rigorous criteria are applied into the
classiﬁcation process in Korea, including lack of family support
and/or incapability of labor as well as low income. Therefore,
the type of health security system could serve as a rough esti-
mate for each patient's socioeconomic status in Korea, and it
could be postulated that economic and functional status of
patients and family support for themwould generally affect the
clinical outcomes in PD patients.
In the present study, cancer was a negative predictor for
technique failure in the Fine and Gray model. Frequent medical
checkup and paying more attention to their own health status
would be associated with lower technique failure rates in PD
patients with cancer. On the other hand, cancer is awell-known
risk factor for mortality in PD patients [3]. When considering
poor survival rate and lowactivity in ESRD patients with cancer,
it is unlikely to change dialysis modalities without any inevi-
table reason.
Our study had several limitations. First, the database used in
this study provided insufﬁcient individual characteristics,
inadequate clinical information, and no speciﬁc laboratory data.
We could not collect data on membrane characteristics, resid-
ual renal function, health literacy level, and timing of referral to
the nephrologists. Therefore, more valuable independent pre-
dictors could not be identiﬁed. In addition, the database did not
include data on the cause of technique failure such as perito-
nitis, thus we could not recommend any speciﬁc strategy to
decrease the technique failure rate in the future. Second, we
excluded cases of technique failure that occurred within 3
months from commencing dialysis therapy because we would
like to include only patients on “long-term dialysis” in this
study. Descoeudres et al [35] emphasized high technique failure
rate within the ﬁrst 6 months on PD. Therefore, the technique
failure rate in this study is likely to be underestimated. Last, the
present study did not evaluate the effect of renal center char-
acteristics, payment policy, physicians' acknowledgment, and
patients' awareness for dialysis modality selection at dialysis
initiation on technique failure in PD patients.
In spite of database-related inherent limitations, this is the
ﬁrst study on technique failure among Asian dialysis patients
that used a national population-based data set. Technique
failure was still a major concern in patients initiating PD in
Korea, especially in diabetic patients and Medical Aid beneﬁ-
ciaries. The results of our study offer a basis for risk stratiﬁca-
tion for technique failure.
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